The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
The Fanconi Anemia/BRCA pathway: new faces in the crowd
Open accessAbstract
Over the past few years, study of the rare inherited chromosome instability disorder, Fanconi Anemia (FA), has uncovered a novel DNA damage response pathway. Through the cooperation of multiple proteins, this pathway regulates a complicated cellular response to DNA cross-linking agents and other genotoxic stresses. In this article we review recent data identifying new components of the FA pathway that implicate it in several aspects of the DNA damage response, including the direct processing of DNA, translesion synthesis, homologous recombination, and cell cycle regulation. We also discuss new findings that explain how the FA pathway is regulated through the processes of ubiquitination and deubiquitination. We then consider the clinical implications of our current understanding of the FA pathway, particularly in the development and treatment of malignancy in heterozygous carriers of FA mutations or in patients with sporadic cancers. We consider how recent studies of p53-mediated apoptosis and loss of p53 function in models of FA may help explain the clinical features of the disease and finally present a hypothesis to account for the specificity of the FA pathway in the response to DNA cross-links.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Sensing DNA Damage Through ATRIP Recognition of RPA-ssDNA Complexes
Zou, L., & Elledge, S. J. (2003) · Science · doi:10.1126/science.1083430 · Cited by 2,693
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
King, M.-C., Marks, J. H., & Mandell, J. B. (2003) · Science · doi:10.1126/science.1088759 · Cited by 2,229
Risks of cancer in BRCA1-mutation carriers
FORD, D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91578-4 · Cited by 1,850 · cited 1×
“Also, in families carrying a BRCA1 or BRCA2/FANCD1 mutation, the peak age of onset of breast or ovarian cancer is in the fourth decade (Ford et al. 1994), whereas FA patients often die from complications of aplastic anemia or other cancers before this age.”
BackgroundLiu, Q., Guntuku, S., Cui, X.-S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., et al. (2000) · Genes & Development · doi:10.1101/gad.14.12.1448 · Cited by 1,625
Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations
Rebbeck, T. R., Lynch, H. T., Neuhausen, S. L., Narod, S. A., van't Veer, L., Garber, J. E., Evans, G., Isaacs, C., Daly, M. B., Matloff, E., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012158 · Cited by 1,465
Brca1 Controls Homology-Directed DNA Repair
Moynahan, M. E., Chiu, J. W., Koller, B. H., & Jasin, M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80202-6 · Cited by 1,245
Interaction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway
Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M. S., Timmers, C., Hejna, J., Grompe, M., & D'Andrea, A. D. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00173-3 · Cited by 1,198
Self-citationBiallelic Inactivation of BRCA2 in Fanconi Anemia
Howlett, N. G., Taniguchi, T., Olson, S., Cox, B., Waisfisz, Q., de Die-Smulders, C., Persky, N., Grompe, M., Joenje, H., Pals, G., et al. (2002) · Science · doi:10.1126/science.1073834 · Cited by 1,149
Self-citationBRCA2 Is Required for Homology-Directed Repair of Chromosomal Breaks
Moynahan, M. E., Pierce, A. J., & Jasin, M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00174-5 · Cited by 1,006
Mechanism and function of deubiquitinating enzymes
Amerik, A. Y., & Hochstrasser, M. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2004.10.003 · Cited by 974
The BRCT Domain Is a Phospho-Protein Binding Domain
Yu, X., Chini, C. C. S., He, M., Mer, G., & Chen, J. (2003) · Science · doi:10.1126/science.1088753 · Cited by 862
The Fanconi anaemia/BRCA pathway
D'Andrea, A. D., & Grompe, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc970 · Cited by 822 · cited 1×
“Fanconi Anemia (FA) is a rare autosomal recessive and X-linked disorder characterized by congenital abnormalities, progressive bone marrow failure, and cancer susceptibility (Joenje and Patel 2001; Bagby Jr. 2003; D’Andrea and Grompe 2003).”
BackgroundSelf-citationChecking on DNA damage in S phase
Bartek, J., Lukas, C., & Lukas, J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1493 · Cited by 758
Cantor, S. B., Bell, D. W., Ganesan, S., Kass, E. M., Drapkin, R., Grossman, S., Wahrer, D. C. R., Sgroi, D. C., Lane, W. S., Haber, D. A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00304-x · Cited by 674
Association of BRCA1 with the hRad50-hMre11-p95 Complex and the DNA Damage Response
Zhong, Q., Chen, C.-F., Li, S., Chen, Y., Wang, C.-C., Xiao, J., Chen, P.-L., Sharp, Z. D., & Lee, W.-H. (1999) · Science · doi:10.1126/science.285.5428.747 · Cited by 626
Cloning of cDNAs for Fanconi's anaemia by functional complementation
Strathdee, C. A., Gavish, H., Shannon, W. R., & Buchwald, M. (1992) · Nature · doi:10.1038/356763a0 · Cited by 624
A 20-year perspective on the International Fanconi Anemia Registry (IFAR)
Kutler, D. I., Singh, B., Satagopan, J., Batish, S. D., Berwick, M., Giampietro, P. F., Hanenberg, H., & Auerbach, A. D. (2003) · Blood · doi:10.1182/blood-2002-07-2170 · Cited by 618
ATM and ATR: networking cellular responses to DNA damage
Shiloh, Y. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00159-3 · Cited by 601
The Deubiquitinating Enzyme USP1 Regulates the Fanconi Anemia Pathway
Nijman, S. M. B., Huang, T. T., Dirac, A. M. G., Brummelkamp, T. R., Kerkhoven, R. M., D'Andrea, A. D., & Bernards, R. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.01.008 · Cited by 588
Self-citationThe emerging genetic and molecular basis of Fanconi anaemia
Joenje, H., & Patel, K. J. (2001) · Nature Reviews Genetics · doi:10.1038/35076590 · Cited by 572
Ubiquitination and deubiquitination: Targeting of proteins for degradation by the proteasome
Wilkinson, K. D. (2000) · Seminars in Cell & Developmental Biology · doi:10.1006/scdb.2000.0164 · Cited by 569
A novel ubiquitin ligase is deficient in Fanconi anemia
Meetei, A. R., de Winter, J. P., Medhurst, A. L., Wallisch, M., Waisfisz, Q., van de Vrugt, H. J., Oostra, A. B., Yan, Z., Ling, C., Bishop, C. E., et al. (2003) · Nature Genetics · doi:10.1038/ng1241 · Cited by 568
Repair of DNA interstrand cross-links
Dronkert, M. L. G., & Kanaar, R. (2001) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(01)00092-1 · Cited by 555
Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumors
Taniguchi, T., Tischkowitz, M., Ameziane, N., Hodgson, S. V., Mathew, C. G., Joenje, H., Mok, S. C., & D'Andrea, A. D. (2003) · Nature Medicine · doi:10.1038/nm852 · Cited by 536
Self-citationOrlicky, S., Tang, X., Willems, A., Tyers, M., & Sicheri, F. (2003) · Cell · doi:10.1016/s0092-8674(03)00034-5 · Cited by 509
BRCA2 germline mutations in familial pancreatic carcinoma
Hahn, S. A., Greenhalf, B., Ellis, I., Sina-Frey, M., Rieder, H., Korte, B., Gerdes, B., Kress, R., Ziegler, A., Raeburn, J. A., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.3.214 · Cited by 480
BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis.
Quinn, J. E., Kennedy, R. D., Mullan, P. B., Gilmore, P. M., Carty, M., Johnston, P. G., & Harkin, D. P. (2003) · PubMed · Cited by 464
Self-citationS-phase–specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51
Taniguchi, T., Garcia-Higuera, I., Andreassen, P. R., Gregory, R. C., Grompe, M., & D'Andrea, A. D. (2002) · Blood · doi:10.1182/blood-2002-01-0278 · Cited by 461
Self-citationMoynahan, M. E., Cui, T. Y., & Jasin, M. (2001) · PubMed · Cited by 457
Meetei, A. R., Medhurst, A. L., Ling, C., Xue, Y., Singh, T. R., Bier, P., Steltenpool, J., Stone, S., Dokal, I., Mathew, C. G., et al. (2005) · Nature Genetics · doi:10.1038/ng1626 · Cited by 455
Convergence of the Fanconi Anemia and Ataxia Telangiectasia Signaling Pathways
Taniguchi, T., Garcia-Higuera, I., Xu, B., Andreassen, P. R., Gregory, R. C., Kim, S.-T., Lane, W. S., Kastan, M. B., & D'Andrea, A. D. (2002) · Cell · doi:10.1016/s0092-8674(02)00747-x · Cited by 449
Self-citationSpecialized DNA Polymerases, Cellular Survival, and the Genesis of Mutations
Friedberg, E. C., Wagner, R., & Radman, M. (2002) · Science · doi:10.1126/science.1070236 · Cited by 443 · cited 1×
“CPD damage is either repaired by nucleotide excision repair (NER) or bypassed by TLS (Friedberg et al. 2002; Prakash and Prakash 2002).”
BackgroundImproved survival in women with BRCA‐associated ovarian carcinoma
Cass, I., Baldwin, R. L., Varkey, T., Moslehi, R., Narod, S. A., & Karlan, B. Y. (2003) · Cancer · doi:10.1002/cncr.11310 · Cited by 433
The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J
Levitus, M., Waisfisz, Q., Godthelp, B. C., Vries, Y. D., Hussain, S., Wiegant, W. W., Elghalbzouri-Maghrani, E., Steltenpool, J., Rooimans, M. A., Pals, G., et al. (2005) · Nature Genetics · doi:10.1038/ng1625 · Cited by 432
Cancer in Fanconi anemia, 1927–2001
Alter, B. P. (2003) · Cancer · doi:10.1002/cncr.11046 · Cited by 432
The Role of BRCA1 in the Cellular Response to Chemotherapy
Kennedy, R. D., Quinn, J. E., Mullan, P. B., Johnston, P. G., & Harkin, D. P. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh312 · Cited by 430
Self-citationTutt, A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.17.4704 · Cited by 429
ATR couples FANCD2 monoubiquitination to the DNA-damage response
Andreassen, P. R., D'Andrea, A. D., & Taniguchi, T. (2004) · Genes & Development · doi:10.1101/gad.1196104 · Cited by 408
Self-citationCancer Risks for Male Carriers of Germline Mutations in BRCA1 or BRCA2: A Review of the Literature
Liede, A., Karlan, B. Y., & Narod, S. A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.055 · Cited by 407
Positional Cloning of a Novel Fanconi Anemia Gene, FANCD2
Timmers, C., Taniguchi, T., Hejna, J., Reifsteck, C., Lucas, L., Bruun, D., Thayer, M., Cox, B., Olson, S., D'Andrea, A. D., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00172-1 · Cited by 404
Self-citationExpression cloning of a cDNA for the major Fanconi anaemia gene, FAA
Lo Ten Foe, J. R., Rooimans, M. A., Bosnoyan-Collins, L., Alon, N., Wijker, M., Parker, L., Lightfoot, J., Carreau, M., Callen, D. F., Savoia, A., et al. (1996) · Nature Genetics · doi:10.1038/ng1196-320 · Cited by 400
Litman, R., Peng, M., Jin, Z., Zhang, F., Zhang, J., Powell, S., Andreassen, P. R., & Cantor, S. B. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.004 · Cited by 396
Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair
Nakanishi, K., Yang, Y.-G., Pierce, A. J., Taniguchi, T., Digweed, M., D'Andrea, A. D., Wang, Z.-Q., & Jasin, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407796102 · Cited by 384 · cited 3×
“In general, disruption of upstream FA proteins, such as FANCA (Nakanishi et al. 2005) and FANCG (Yamamoto et al.”
BackgroundSelf-citationThe Bloom's Syndrome Gene Product Is a 3′-5′ DNA Helicase
Karow, J. K., Chakraverty, R. K., & Hickson, I. D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.49.30611 · Cited by 378
Trading Places: How Do DNA Polymerases Switch during Translesion DNA Synthesis?
Friedberg, E. C., Lehmann, A. R., & Fuchs, R. P. P. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.032 · Cited by 375
The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia
Levran, O., Attwooll, C., Henry, R. T., Milton, K. L., Neveling, K., Rio, P., Batish, S. D., Kalb, R., Velleuer, E., Barral, S., et al. (2005) · Nature Genetics · doi:10.1038/ng1624 · Cited by 370
High Incidence of Head and Neck Squamous Cell Carcinoma in Patients With Fanconi Anemia
Kutler, D. I., Auerbach, A. D., Satagopan, J., Giampietro, P. F., Batish, S. D., Huvos, A. G., Goberdhan, A., Shah, J. P., & Singh, B. (2003) · Archives of Otolaryngology–Head & Neck Surgery · doi:10.1001/archotol.129.1.106 · Cited by 370
A Multiprotein Nuclear Complex Connects Fanconi Anemia and Bloom Syndrome
Meetei, A. R., Sechi, S., Wallisch, M., Yang, D., Young, M. K., Joenje, H., Hoatlin, M. E., & Wang, W. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.10.3417-3426.2003 · Cited by 356
Translesion DNA synthesis in eukaryotes: A one- or two-polymerase affair
Prakash, S., & Prakash, L. (2002) · Genes & Development · doi:10.1101/gad.1009802 · Cited by 344
The Fanconi anaemia group G gene FANCG is identical with XRCC9
de Winter, J. P., Waisfisz, Q., Rooimans, M. A., van Berkel, C. G. M., Bosnoyan-Collins, L., Alon, N., Carreau, M., Bender, O., Demuth, I., Schindler, D., et al. (1998) · Nature Genetics · doi:10.1038/3093 · Cited by 335
Functional Interaction of Monoubiquitinated FANCD2 and BRCA2/FANCD1 in Chromatin
Wang, X., Andreassen, P. R., & D'Andrea, A. D. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.5850-5862.2004 · Cited by 333
Self-citationX-linked inheritance of Fanconi anemia complementation group B
Meetei, A. R., Levitus, M., Xue, Y., Medhurst, A. L., Zwaan, M., Ling, C., Rooimans, M. A., Bier, P., Hoatlin, M., Pals, G., et al. (2004) · Nature Genetics · doi:10.1038/ng1458 · Cited by 325
The Fanconi Anaemia Gene FANCC Promotes Homologous Recombination and Error-Prone DNA Repair
Niedzwiedz, W., Mosedale, G., Johnson, M., Ong, C. Y., Pace, P., & Patel, K. J. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.08.009 · Cited by 308
Brosh, R. M., Li, J.-L., Kenny, M. K., Karow, J. K., Cooper, M. P., Kureekattil, R. P., Hickson, I. D., & Bohr, V. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001557200 · Cited by 299
DNA adducts from chemotherapeutic agents
Lawley, P. D., & Phillips, D. H. (1996) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/0027-5107(96)00020-6 · Cited by 294
Evidence for at least four Fanconi anaemia genes including FACC on chromosome 9
Strathdee, C. A., Duncan, A. M. V., & Buchwald, M. (1992) · Nature Genetics · doi:10.1038/ng0692-196 · Cited by 289
Howlett, N. G., Taniguchi, T., Durkin, S. G., D'Andrea, A. D., & Glover, T. W. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi065 · Cited by 280
Self-citationInteraction of FANCD2 and NBS1 in the DNA damage response
Nakanishi, K., Taniguchi, T., Ranganathan, V., New, H. V., Moreau, L. A., Stotsky, M., Mathew, C. G., Kastan, M. B., Weaver, D. T., & D'Andrea, A. D. (2002) · Nature Cell Biology · doi:10.1038/ncb879 · Cited by 272
Self-citationDeubiquitinating Enzymes: A New Class of Biological Regulators
D'Andrea, A., & Pellman, D. (1998) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409239891204251 · Cited by 271
Self-citationFanconi's anemia and malignancies
Alter, B. P. (1996) · American Journal of Hematology · doi:10.1002/(sici)1096-8652(199610)53:2<99::aid-ajh7>3.0.co;2-z · Cited by 267
The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM
de Winter, J. P., Rooimans, M. A., van der Weel, L., van Berkel, C. G. M., Alon, N., Bosnoyan-Collins, L., de Groot, J., Zhi, Y., Waisfisz, Q., Pronk, J. C., et al. (2000) · Nature Genetics · doi:10.1038/71626 · Cited by 266
Stabilization of stalled DNA replication forks by the BRCA2 breast cancer susceptibility protein
Lomonosov, M., Anand, S., Sangrithi, M., Davies, R., & Venkitaraman, A. R. (2003) · Genes & Development · doi:10.1101/gad.279003 · Cited by 256
Alter, B. P., Greene, M. H., Velazquez, I., & Rosenberg, P. S. (2003) · Blood · doi:10.1182/blood-2002-11-3597 · Cited by 244
Cantor, S., Drapkin, R., Zhang, F., Lin, Y., Han, J., Pamidi, S., & Livingston, D. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308717101 · Cited by 240
Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes
Levitus, M., Rooimans, M. A., Steltenpool, J., Cool, N. F. C., Oostra, A. B., Mathew, C. G., Hoatlin, M. E., Waisfisz, Q., Arwert, F., de Winter, J. P., et al. (2004) · Blood · doi:10.1182/blood-2003-08-2915 · Cited by 240
Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains
Rodriguez, M., Yu, X., Chen, J., & Songyang, Z. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300407200 · Cited by 234
Marsit, C. J., Liu, M., Nelson, H. H., Posner, M., Suzuki, M., & Kelsey, K. T. (2004) · Oncogene · doi:10.1038/sj.onc.1207256 · Cited by 228
The DNA crosslink‐induced S‐phase checkpoint depends on ATR–CHK1 and ATR–NBS1–FANCD2 pathways
Pichierri, P., & Rosselli, F. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600113 · Cited by 223
Isolation of a cDNA Representing the Fanconi Anemia Complementation Group E Gene
de Winter, J. P., Léveillé, F., van Berkel, C. G. M., Rooimans, M. A., van der Weel, L., Steltenpool, J., Demuth, I., Morgan, N. V., Alon, N., Bosnoyan-Collins, L., et al. (2000) · The American Journal of Human Genetics · doi:10.1016/s0002-9297(07)62959-0 · Cited by 222
Rothfuss, A., & Grompe, M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.1.123-134.2004 · Cited by 220
Helt, C. E., Cliby, W. A., Keng, P. C., Bambara, R. A., & O'Reilly, M. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410873200 · Cited by 216
Bridge, W. L., Vandenberg, C. J., Franklin, R. J., & Hiom, K. (2005) · Nature Genetics · doi:10.1038/ng1627 · Cited by 211
Direct interaction of FANCD2 with BRCA2 in DNA damage response pathways
Hussain, S. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh135 · Cited by 208
NBS1 and its functional role in the DNA damage response
Kobayashi, J., Antoccia, A., Tauchi, H., Matsuura, S., & Komatsu, K. (2004) · DNA Repair · doi:10.1016/j.dnarep.2004.03.023 · Cited by 202
Homologous recombination-mediated double-strand break repair
Wyman, C., Ristic, D., & Kanaar, R. (2004) · DNA Repair · doi:10.1016/j.dnarep.2004.03.037 · Cited by 195
The vertebrate Hef ortholog is a component of the Fanconi anemia tumor-suppressor pathway
Mosedale, G., Niedzwiedz, W., Alpi, A., Perrina, F., Pereira-Leal, J. B., Johnson, M., Langevin, F., Pace, P., & Patel, K. J. (2005) · Nature Structural & Molecular Biology · doi:10.1038/nsmb981 · Cited by 192
Promoter Hypermethylation of FANCF
Narayan, G., Arias-Pulido, H., Nandula, S. V., Basso, K., Sugirtharaj, D. D., Vargas, H., Mansukhani, M., Villella, J., Meyer, L., Schneider, A., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0245 · Cited by 190
Genetic basis of Fanconi anemia
Bagby, G. C. (2003) · Current Opinion in Hematology · doi:10.1097/00062752-200301000-00011 · Cited by 183
FANCE: the link between Fanconi anaemia complex assembly and activity
Pace, P. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf355 · Cited by 173
Kutler, D. I. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg091 · Cited by 168
A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer: Table 1
Chappuis, P. O., Goffin, J., Wong, N., Perret, C., Ghadirian, P., Tonin, P. N., & Foulkes, W. D. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.8.608 · Cited by 156
Vertebrate DNA damage tolerance requires the C-terminus but not BRCT or transferase domains of REV1
Ross, A.-L., Simpson, L. J., & Sale, J. E. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki279 · Cited by 154
Requirement of DNA Polymerase η for Error-Free Bypass of UV-Induced CC and TC Photoproducts
Yu, S.-L., Johnson, R. E., Prakash, S., & Prakash, L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.1.185-188.2001 · Cited by 149
RAD18 and RAD54 cooperatively contribute to maintenance of genomic stability in vertebrate cells
Yamashita, Y. M., Okada, T., Matsusaka, T., Sonoda, E., Zhao, G. Y., Araki, K., Tateishi, S., Yamaizumi, M., & Takeda, S. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf534 · Cited by 149
Germ Line Fanconi Anemia Complementation Group C Mutations and Pancreatic Cancer
Couch, F. J., Johnson, M. R., Rabe, K. G., Boardman, L., McWilliams, R. R., de Andrade, M., & Petersen, G. M. (2005) · Cancer Research · doi:10.1158/0008-5472.383.65.2 · Cited by 146
Yamamoto, K., Ishiai, M., Matsushita, N., Arakawa, H., Lamerdin, J., Buerstedde, J., Tanimoto, M., Harada, M., Thompson, L., & Takata, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.15.5421-5430.2003 · Cited by 142
Eme1 is involved in DNA damage processing and maintenance of genomic stability in mammalian cells
Abraham, J., Lemmers, B., Hande, M. P., Moynahan, M. E., Chahwan, C., Ciccia, A., Essers, J., Hanada, K., Chahwan, R., Khaw, A. K., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg580 · Cited by 136
Functional relationships of FANCC to homologous recombination, translesion synthesis, and BLM
Hirano, S., Yamamoto, K., Ishiai, M., Yamazoe, M., Seki, M., Matsushita, N., Ohzeki, M., Yamashita, Y. M., Arakawa, H., Buerstedde, J.-M., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600534 · Cited by 133
Analysis of the DNA Substrate Specificity of the Human BACH1 HelicaseAssociated with BreastCancer
Gupta, R., Sharma, S., Sommers, J. A., Jin, Z., Cantor, S. B., & Brosh, R. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501995200 · Cited by 131 · cited 2×
“strates an in vitro 5 –3 DNA unwinding activity of forked DNA duplexes whereas BLM demonstrates a 3 – 5 helicase activity (Karow et al. 1997; Gupta et al. 2005).”
BackgroundBRCA1-independent ubiquitination of FANCD2
Vandenberg, C. J., Gergely, F., Ong, C. Y., Pace, P., Mallery, D. L., Hiom, K., & Patel, K. J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00281-8 · Cited by 131
Functional Defects in the Fanconi Anemia Pathway in Pancreatic Cancer Cells
van der Heijden, M. S., Brody, J. R., Gallmeier, E., Cunningham, S. C., Dezentjé, D. A., Shen, D., Hruban, R. H., & Kern, S. E. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63329-9 · Cited by 129
García-Higuera, I., Kuang, Y., Denham, J., & D’Andrea, A. D. (2000) · Blood · doi:10.1182/blood.v96.9.3224 · Cited by 127
Self-citationPapadopoulo, D., Guillouf, C., Mohrenweiser, H. W., & Moustacchi, E. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.21.8383 · Cited by 126
Elledge, S. J., & Amon, A. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00041-7 · Cited by 119
Knockdown of Zebrafish Fancd2 Causes Developmental Abnormalities via p53-Dependent Apoptosis
Liu, T. X., Howlett, N. G., Deng, M., Langenau, D. M., Hsu, K., Rhodes, J., Kanki, J. P., D’Andrea, A. D., & Look, A. T. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00339-3 · Cited by 115
Self-citationNew tools for functional mammalian cancer genetics
Brummelkamp, T. R., & Bernards, R. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1191 · Cited by 114
Novel endonuclease in Archaea cleaving DNA with various branched structure.
Komori, K., Fujikane, R., Shinagawa, H., & Ishino, Y. (2002) · Genes & Genetic Systems · doi:10.1266/ggs.77.227 · Cited by 107
DNA cross-link-dependent RAD50/MRE11/NBS1 subnuclear assembly requires the Fanconi anemia C protein
Pichierri, P., Averbeck, D., & Rosselli, F. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.21.2531 · Cited by 105
Sridharan, D., Brown, M., Lambert, W. C., McMahon, L., & Lambert, M. W. (2003) · Journal of Cell Science · doi:10.1242/jcs.00294 · Cited by 104
Involvement of Vertebrate Polκ in Rad18-independent Postreplication Repair of UV Damage
Okada, T., Sonoda, E., Yamashita, Y. M., Koyoshi, S., Tateishi, S., Yamaizumi, M., Takata, M., Ogawa, O., & Takeda, S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207957200 · Cited by 99
Regulation of the Fanconi anemia pathway by monoubiquitination
Gregory, R. C., Taniguchi, T., & D’Andrea, A. D. (2002) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00102-5 · Cited by 94
Self-citationDeletion and reduced expression of the Fanconi anemia FANCA gene in sporadic acute myeloid leukemia
Tischkowitz, M. D., Morgan, N. V., Grimwade, D. J., Eddy, C.-A., Ball, S. E., Vořechovský, I., Langabeer, S. E., Stöger, R. J., Hodgson, S. V., & Mathew, C. G. (2004) · Leukemia · doi:10.1038/sj.leu.2403280 · Cited by 91
Dhillon, V. S., Shahid, M., & Husain, S. A. (2004) · Molecular Cancer · doi:10.1186/1476-4598-3-33 · Cited by 89
Kubbies, M., Schindler, D., Hoehn, H., Schinzel, A., & Rabinovitch, P. S. (1985) · PubMed · doi:10.5167/uzh-237358 · Cited by 86
Foe, J. R. L. T., Rooimans, M. A., Bosnoyan-Collins, L., Alon, N., Wijker, M., Parker, L., Lightfoot, J., Carreau, M., Callen, D. F., Savoia, A., et al. (1996) · Nature Genetics · Cited by 85
Effects of ionizing radiation on cells from Fanconi's anemia patients.
Duckworth-Rysiecki, G., & Taylor, A. M. R. (1985) · PubMed · Cited by 79
The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC
Taniguchi, T., & D’Andrea, A. D. (2002) · Blood · doi:10.1182/blood-2002-03-0860 · Cited by 79
Self-citationArrest of S-Phase Progression Is Impaired in Fanconi Anemia Cells
Sala-Trepat, M., Rouillard, D., Escarceller, M., Laquerbe, A., Moustacchi, E., & Papadopoulo, D. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4994 · Cited by 78
Yang, Y., Herceg, Z., Nakanishi, K., Demuth, I., Piccoli, C., Michelon, J., Hildebrand, G., Jasin, M., Digweed, M., & Wang, Z. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi134 · Cited by 77
Interlaboratory validation of a new assay for DNA-protein crosslinks
Costa, M., Zhitkovich, A., Gargas, M. L., Paustenbach, D. J., Finley, B. L., Kuykendall, J. R., Billings, R. E., Carlson, T. J., Wetterhahn, K. E., Xu, J. Y., et al. (1996) · Mutation Research/Genetic Toxicology · doi:10.1016/s0165-1218(96)90043-9 · Cited by 75
German, J., Schonberg, S., Caskie, S., Warburton, D., Falk, C., & Ray, J. (1987) · Blood · doi:10.1182/blood.v69.6.1637.1637 · Cited by 75
The 4N Cell Cycle Delay in Fanconi Anemia Reflects Growth Arrest in Late S Phase
Akkari, Y. M. N., Bateman, R. L., Reifsteck, C. A., D’Andrea, A. D., Olson, S. B., & Grompe, M. (2001) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2001.3259 · Cited by 73
Self-citationFanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems
Gordon, S. M., & Buchwald, M. (2003) · Blood · doi:10.1182/blood-2002-11-3517 · Cited by 73
Carreau, M., Alon, N., Bosnoyan-Collins, L., Joenje, H., & Buchwald, M. (1999) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(99)00041-5 · Cited by 67
The Bloom's syndrome helicase stimulates the activity of human topoisomerase IIIalpha
Wu, L. J. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf611 · Cited by 66
Risinger, M. A., & Groden, J. L. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.12.001 · Cited by 65
The molecular basis of radiosensitivity and chemosensitivity in the treatment of breast cancer
Xia, F., & Powell, S. N. (2002) · Seminars in Radiation Oncology · doi:10.1053/srao.2002.35250 · Cited by 62
Houghtaling, S. R., Granville, L. A., Akkari, Y. M. N., Torimaru, Y., Olson, S. B., Finegold, M. J., & Grompe, M. (2005) · Cancer Research · doi:10.1158/0008-5472.85.65.1 · Cited by 61
The Fanconi anemia core complex associates with chromatin during S phase
Mi, J., & Kupfer, G. M. (2004) · Blood · doi:10.1182/blood-2004-01-0001 · Cited by 60
Nine novel conserved motifs in BRCA1 identified by the chicken orthologue
Orelli, B. J., Logsdon, J. M., Jr., & Bishop, D. K. (2001) · Oncogene · doi:10.1038/sj.onc.1204485 · Cited by 45
Damage-Resistant DNA Synthesis in Fanconi Anemia Cells Treated with a DNA Cross-Linking Agent
Centurión, S. A., Kuo, H.-R., & Lambert, W. C. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4995 · Cited by 43
Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells
Xie, Y., de Winter, J. P., Waisfisz, Q., Nieuwint, A. W. M., Scheper, R. J., Arwert, F., Hoatlin, M. E., Ossenkoppele, G. J., Schuurhuis, G., & Joenje, H. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02450.x · Cited by 43
A Role for the Fanconi Anemia C Protein in Maintaining the DNA Damage-induced G2 Checkpoint
Freie, B. W., Ciccone, S. L. M., Li, X., Plett, P. A., Orschell, C. M., Srour, E. F., Hanenberg, H., Schindler, D., Lee, S., & Clapp, D. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407160200 · Cited by 40
Analysis of the Fanconi Anaemia Complentation Group A Gene in Acute Myeloid Leukaemia
Condie, A., Powles, R., Hudson, C. D., Shepherd, V., Bevan, S., Yuille, M., & Houlston, R. S. (2002) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042819021000009274 · Cited by 36
Trading Places: How Do DNA Polymerases Switch during Translesion DNA Synthesis?
Friedberg, E. C., Lehmann, A. R., & Fuchs, R. P. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.06.003 · Cited by 34
Deficient Regulation of DNA Double-strand Break Repair in Fanconi Anemia Fibroblasts
Donahue, S. L., Lundberg, R., Saplis, R., & Campbell, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m213251200 · Cited by 32
Poll, E. H. A., Arwert, F., Joenje, H., & Wanamarta, A. H. (1985) · Human Genetics · doi:10.1007/bf00284574 · Cited by 31
Jonnalagadda, V. S., Matsuguchi, T., & Engelward, B. P. (2005) · DNA repair · doi:10.1016/j.dnarep.2005.02.002 · Cited by 28
Possible anti-recombinogenic role of Bloom's syndrome helicase in double-strand break processing
Onclercq, R., Calsou, P., Delteil, C., Salles, B., Papadopoulo, D., & Amor-Guéret, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg834 · Cited by 24
A simple diagnostic test for Fanconi anemia by flow cytometry.
Miglierina, R., Coniat, M. L., & Berger, R. (1991) · PubMed · Cited by 22
Papadopoulo, D., Guillouf, C., Porfirio, B., & Moustacchi, E. (1990) · PubMed · Cited by 9
Cited by
The DNA-damage response in human biology and disease
Jackson, S. P., & Bartek, J. (2009) · Nature · doi:10.1038/nature08467 · Cited by 6,092
Mechanism of Eukaryotic Homologous Recombination
San Filippo, J., Sung, P., & Klein, H. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.061306.125255 · Cited by 1,681
Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes.
Reyes-Turcu, F. E., Ventii, K. H., & Wilkinson, K. D. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.082307.091526 · Cited by 1,396
Homologous recombination in DNA repair and DNA damage tolerance
Li, X., & Heyer, W.-D. (2008) · Cell Research · doi:10.1038/cr.2008.1 · Cited by 1,197
Chromosome Abnormalities and Genetic Counseling
Gardner, R. J. M., Sutherland, G. R., & Shaffer, L. G. (2011) · Oxford University Press eBooks · doi:10.1093/med/9780195375336.001.0001 · Cited by 857
Metadata
- Authors
- Kennedy, R. D., & D'Andrea, A. D.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2005-12-15
- Volume
- 19
- Issue
- 24
- Pages
- 2925-2940
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2130151956
- Cited by
- 467
- References
- 134
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.